Filing Flows › Traws Pharma (TRAW) › R&D spending
Traws Pharma (TRAW) R&D spending by quarter
Traws Pharma's R&D spending was $2.3M in Q2 2025 (second quarter 2025), -9% from Q1 2025. Over the last 3 quarters it ranged from $1.9M (Q4 2024) to $2.5M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2025 | $2.3M | -9% | — |
| Q1 2025 | $2.5M | +35% | — |
| Q4 2024 | $1.9M | — | — |
Q2 2025 at a glance
Traws Pharma, Q2 2025: revenue $2.7M (48× year over year), operating margin -45.7%, net loss $915K, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Traws Pharma's R&D spending?
Traws Pharma's R&D spending was $2.3M in Q2 2025 (second quarter 2025), -9% from Q1 2025.
How has Traws Pharma's R&D spending changed?
Over the last 3 quarters it ranged from $1.9M (Q4 2024) to $2.5M (Q1 2025).